Product Information
TOPIRAMATE 15 MG SPRINKLE CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2294 per EA under NDC 68382000414. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 14, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382000414
Classification
Generic
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA078877FDA Approved
10/14/2009
TE Code
AB
On Market Since
10/14/2009
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 15 MG SPRINKLE CAP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2294 per EA |
|---|---|
| All-time high | $0.7713 (Jun 12, 2024) |
| All-time low | $0.2294 (Sep 23, 2026) |
| 52-week high | $0.3505 |
| 52-week low | $0.2294 |
| Median price | $0.3853 |
| Average price | $0.4509 |
| Largest weekly change | +48.0% (Jan 22, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
topiramate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 15 MG SPRINKLE CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 15 MG SPRINKLE CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2294 per EA (NDC 68382000414), effective Sep 30, 2026.
How has the price of TOPIRAMATE 15 MG SPRINKLE CAP changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 15 MG SPRINKLE CAP has declined 40.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 15 MG SPRINKLE CAP?
Since Nov 28, 2013, the NADAC for TOPIRAMATE 15 MG SPRINKLE CAP has ranged from a low of $0.2294 (Sep 23, 2026) to a high of $0.7713 (Jun 12, 2024), with a median of $0.3853 per EA.
Are there cheaper alternatives to TOPIRAMATE 15 MG SPRINKLE CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE 15 MG SPRINKLE CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures TOPIRAMATE 15 MG SPRINKLE CAP?
TOPIRAMATE 15 MG SPRINKLE CAP (NDC 68382000414) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.